INOVIO PHARMACEUTICALS, INC. - 8-K Filing
Inovio Pharmaceuticals announces $80.5 million public offering of common stock and pre-funded warrants (Items: 1.01 Entry into a Material Definitive Agreement, 7.01 Regulation FD Disclosure Based on the Company’s planned use of proceeds, the Company believes that the net proceeds from the Offering and its, 8.01 Other Events On November 5, 2026, the Company issued press releases announcing the launch and pricing of the Offering, respectively, copies o, 9.01 Financial Statements and Exhibits)
Tickers: $INO
Read the full article at SEC EDGAR
Part of the story 3M CO - 8-K Filing (3 articles)